You are here: Industry Insights > cell and gene therapy

News List

Discovery Life Sciences Appoints Cell & Gene Therapy CTO contractpharma
August 13, 2021
Dr. Clarke will work to further establish the company as a global leader in cell and gene therapy materials and analytical services.
Cell and gene therapy manufacturing services market to value $13.8 billion by 2026 europeanpharmaceuticalreview
August 12, 2021
The global cell and gene therapy manufacturing services market is expected to grow at a CAGR of 12.4 percent in the next five years.
Global Cell & Gene Therapy Mfg. Market Could Reach $57.4B by 2028 contractpharma
August 02, 2021
Market estimated to grow at CAGR of 20% from 2021 to 2028 due to an exponential rise in clinical pipeline along with rising number of regulatory approvals.
Ashfield Launches Cell & Gene Therapy Commercialization Network contractpharma
July 15, 2021
EmerGENE is designed to support small and midsize biotechs with the commercialization of their discoveries.
Sequanta, Mission Bio Enter Strategic Pact contractpharma
July 12, 2021
Sequanta Technologies Co. and Mission Bio have entered into a strategic partnership, providing high-quality single-cell sequence services using Mission Bio's products to customers in mainland China.
Sartorius Strengthens Cell and Gene Therapy Portfolio With Majority Stake of CellGenix americanpharmaceuticalreview
July 05, 2021
Sartorius acquired a majority stake in the reagent manufacturer CellGenix, a German producer and marketer of cell culture components including - growth factors, cytokines and media in GMP quality for manufacturing cell and gene therapy products.
New consortium to develop PAT for cell and gene therapies europeanpharmaceuticalreview
June 17, 2021
The Cell and Gene Therapy Catapult’s new consortium aims to accelerate therapeutic development by developing process analytical technologies (PAT) for cell and gene therapy manufacturing.
Bayer subsidiary doses first patient with Parkinson’s disease cell therapy pharmatimes
June 10, 2021
German pharma company Bayer has announced that it has made progress in its ‘two-pronged’ approach to deliver cell and gene therapy candidates for the treatment of Parkinson’s disease.
Cell and Gene Therapy Catapult forms consortium of over 20 organisations pharmatimes
June 10, 2021
The Cell and Gene Therapy (CGT) Catapult has announced the formation of a consortium of over 20 organisations, which will aim to accelerate technology development in cell and gene therapy manufacturing.
Catalent buys Belgian CDMO to boost pDNA manufacturing and service offering cphi-online
May 24, 2021
New facility at Gosselies site will host commercial scale pDNA manufacturing as Catalent extends its cell and gene therapy footprint

Previous page 1 2 3 4 5 Next page